Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Chst15 | Rat | (+)-dexrazoxane | multiple interactions | ISO | Chst15 (Mus musculus) | 6480464 | [Dexrazoxane co-treated with Doxorubicin] results in decreased expression of CHST15 protein | CTD | PMID:30517846 | Chst15 | Rat | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | CHST15 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CHST15 mRNA | CTD | PMID:22079256 | Chst15 | Rat | 1,1-dichloroethene | decreases expression | ISO | Chst15 (Mus musculus) | 6480464 | vinylidene chloride results in decreased expression of CHST15 mRNA | CTD | PMID:26682919 | Chst15 | Rat | 1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene | multiple interactions | ISO | Chst15 (Mus musculus) | 6480464 | [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with more ... | CTD | PMID:25510870 | Chst15 | Rat | 1,2-dichloroethane | decreases expression | ISO | Chst15 (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of CHST15 mRNA | CTD | PMID:28960355 | Chst15 | Rat | 1,2-dimethylhydrazine | multiple interactions | ISO | Chst15 (Mus musculus) | 6480464 | [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CHST15 mRNA | CTD | PMID:22206623 | Chst15 | Rat | 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of CHST15 mRNA | CTD | PMID:29097150 | Chst15 | Rat | 17beta-estradiol | multiple interactions | ISO | CHST15 (Homo sapiens) | 6480464 | [Estradiol co-treated with Progesterone] results in decreased expression of CHST15 mRNA; [Estradiol co-treated with TGFB1 more ... | CTD | PMID:20660070|PMID:30165855 | Chst15 | Rat | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | Chst15 (Mus musculus) | 6480464 | [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with more ... | CTD | PMID:25510870 | Chst15 | Rat | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | ISO | Chst15 (Mus musculus) | 6480464 | [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with more ... | CTD | PMID:25510870 | Chst15 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Chst15 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CHST15 mRNA | CTD | PMID:21354282 | Chst15 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CHST15 mRNA | CTD | PMID:33387578 | Chst15 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | CHST15 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CHST15 mRNA | CTD | PMID:20106945|PMID:21632981|PMID:26238291 | Chst15 | Rat | 2,4,4'-trichlorobiphenyl | multiple interactions | ISO | Chst15 (Mus musculus) | 6480464 | [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with more ... | CTD | PMID:25510870 | Chst15 | Rat | 3,3',4,4',5-pentachlorobiphenyl | increases expression | EXP | | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CHST15 mRNA | CTD | PMID:23196670 | Chst15 | Rat | 3,3',5,5'-tetrabromobisphenol A | decreases expression | ISO | Chst15 (Mus musculus) | 6480464 | tetrabromobisphenol A results in decreased expression of CHST15 mRNA | CTD | PMID:25172293 | Chst15 | Rat | 4-hydroxyphenyl retinamide | increases expression | ISO | Chst15 (Mus musculus) | 6480464 | Fenretinide results in increased expression of CHST15 mRNA | CTD | PMID:28973697 | Chst15 | Rat | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of CHST15 mRNA | CTD | PMID:31881176 | Chst15 | Rat | all-trans-retinoic acid | increases expression | ISO | CHST15 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of CHST15 mRNA | CTD | PMID:18052213|PMID:21934132|PMID:33167477 | Chst15 | Rat | all-trans-retinoic acid | decreases expression | ISO | CHST15 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of CHST15 mRNA | CTD | PMID:23724009 | Chst15 | Rat | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of CHST15 mRNA | CTD | PMID:16483693 | Chst15 | Rat | amphetamine | decreases expression | EXP | | 6480464 | Amphetamine results in decreased expression of CHST15 mRNA | CTD | PMID:30779732 | Chst15 | Rat | ampicillin | increases expression | ISO | CHST15 (Homo sapiens) | 6480464 | Ampicillin results in increased expression of CHST15 mRNA | CTD | PMID:21632981 | Chst15 | Rat | antirheumatic drug | decreases expression | ISO | CHST15 (Homo sapiens) | 6480464 | Antirheumatic Agents results in decreased expression of CHST15 mRNA | CTD | PMID:24449571 | Chst15 | Rat | arsane | multiple interactions | ISO | CHST15 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Chst15 | Rat | arsenic atom | multiple interactions | ISO | CHST15 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Chst15 | Rat | arsenite(3-) | increases methylation | ISO | CHST15 (Homo sapiens) | 6480464 | arsenite results in increased methylation of CHST15 promoter | CTD | PMID:23974009 | Chst15 | Rat | belinostat | increases expression | ISO | CHST15 (Homo sapiens) | 6480464 | belinostat results in increased expression of CHST15 mRNA | CTD | PMID:27188386 | Chst15 | Rat | benzo[a]pyrene | decreases expression | ISO | Chst15 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of CHST15 mRNA | CTD | PMID:19770486 | Chst15 | Rat | benzo[a]pyrene | increases expression | ISO | CHST15 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of CHST15 mRNA | CTD | PMID:32234424 | Chst15 | Rat | benzo[a]pyrene | affects methylation | ISO | CHST15 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of CHST15 intron | CTD | PMID:30157460 | Chst15 | Rat | benzo[a]pyrene | decreases expression | ISO | CHST15 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of CHST15 mRNA | CTD | PMID:20106945|PMID:21632981|PMID:26238291 | Chst15 | Rat | benzo[a]pyrene | affects expression | ISO | CHST15 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the expression of CHST15 mRNA | CTD | PMID:22316170 | Chst15 | Rat | benzo[a]pyrene | increases expression | ISO | Chst15 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of CHST15 mRNA | CTD | PMID:21569818 | Chst15 | Rat | benzo[a]pyrene diol epoxide I | decreases expression | ISO | CHST15 (Homo sapiens) | 6480464 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of CHST15 mRNA | CTD | PMID:19150397|PMID:20382639 | Chst15 | Rat | benzo[a]pyrene diol epoxide I | increases expression | ISO | CHST15 (Homo sapiens) | 6480464 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of CHST15 mRNA | CTD | PMID:26238291 | Chst15 | Rat | Benzo[k]fluoranthene | increases expression | ISO | Chst15 (Mus musculus) | 6480464 | benzo(k)fluoranthene results in increased expression of CHST15 mRNA | CTD | PMID:26377693 | Chst15 | Rat | bis(2-chloroethyl) sulfide | decreases expression | ISO | CHST15 (Homo sapiens) | 6480464 | Mustard Gas results in decreased expression of CHST15 mRNA | CTD | PMID:12884408 | Chst15 | Rat | bis(2-ethylhexyl) phthalate | decreases expression | ISO | CHST15 (Homo sapiens) | 6480464 | Diethylhexyl Phthalate results in decreased expression of CHST15 mRNA | CTD | PMID:28412506 | Chst15 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of CHST15 mRNA | CTD | PMID:25181051 | Chst15 | Rat | bisphenol A | decreases methylation | ISO | CHST15 (Homo sapiens) | 6480464 | bisphenol A results in decreased methylation of CHST15 gene | CTD | PMID:31601247 | Chst15 | Rat | bisphenol A | multiple interactions | ISO | CHST15 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of CHST15 gene | CTD | PMID:31601247 | Chst15 | Rat | bisphenol A | affects expression | ISO | CHST15 (Homo sapiens) | 6480464 | bisphenol A affects the expression of CHST15 mRNA | CTD | PMID:30903817 | Chst15 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of CHST15 mRNA | CTD | PMID:29097150 | Chst15 | Rat | butan-1-ol | multiple interactions | ISO | CHST15 (Homo sapiens) | 6480464 | [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic more ... | CTD | PMID:29432896 | Chst15 | Rat | C60 fullerene | increases expression | EXP | | 6480464 | fullerene C60 results in increased expression of CHST15 mRNA | CTD | PMID:19167457 | Chst15 | Rat | carbamazepine | affects expression | ISO | CHST15 (Homo sapiens) | 6480464 | Carbamazepine affects the expression of CHST15 mRNA | CTD | PMID:25979313 | Chst15 | Rat | carbon nanotube | decreases expression | ISO | Chst15 (Mus musculus) | 6480464 | Nanotubes, Carbon analog results in decreased expression of CHST15 mRNA; Nanotubes, Carbon results in decreased more ... | CTD | PMID:25554681 | Chst15 | Rat | CGP 52608 | multiple interactions | ISO | CHST15 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to CHST15 gene] | CTD | PMID:28238834 | Chst15 | Rat | chlordecone | increases expression | ISO | Chst15 (Mus musculus) | 6480464 | Chlordecone results in increased expression of CHST15 mRNA | CTD | PMID:33711761 | Chst15 | Rat | chlorpyrifos | increases expression | ISO | Chst15 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of CHST15 mRNA | CTD | PMID:37019170 | Chst15 | Rat | copper(II) sulfate | decreases expression | ISO | CHST15 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of CHST15 mRNA | CTD | PMID:19549813 | Chst15 | Rat | cyclosporin A | decreases expression | ISO | CHST15 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of CHST15 mRNA | CTD | PMID:25562108 | Chst15 | Rat | DDT | increases methylation | EXP | | 6480464 | DDT results in increased methylation of CHST15 gene | CTD | PMID:31682807 | Chst15 | Rat | dexamethasone | increases expression | ISO | Chst15 (Mus musculus) | 6480464 | Dexamethasone results in increased expression of CHST15 mRNA | CTD | PMID:22733784 | Chst15 | Rat | Dibutyl phosphate | affects expression | ISO | CHST15 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of CHST15 mRNA | CTD | PMID:37042841 | Chst15 | Rat | dioxygen | increases expression | ISO | Chst15 (Mus musculus) | 6480464 | Oxygen deficiency results in increased expression of CHST15 mRNA | CTD | PMID:20880076 | Chst15 | Rat | dorsomorphin | multiple interactions | ISO | CHST15 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... | CTD | PMID:27188386 | Chst15 | Rat | doxorubicin | multiple interactions | ISO | Chst15 (Mus musculus) | 6480464 | [Dexrazoxane co-treated with Doxorubicin] results in decreased expression of CHST15 protein | CTD | PMID:30517846 | Chst15 | Rat | doxorubicin | decreases expression | ISO | CHST15 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of CHST15 mRNA | CTD | PMID:29803840 | Chst15 | Rat | doxorubicin | decreases expression | ISO | Chst15 (Mus musculus) | 6480464 | Doxorubicin results in decreased expression of CHST15 protein | CTD | PMID:30517846 | Chst15 | Rat | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of CHST15 mRNA | CTD | PMID:29391264 | Chst15 | Rat | entinostat | multiple interactions | ISO | CHST15 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... | CTD | PMID:27188386 | Chst15 | Rat | entinostat | increases expression | ISO | CHST15 (Homo sapiens) | 6480464 | entinostat results in increased expression of CHST15 mRNA | CTD | PMID:26272509 | Chst15 | Rat | epoxiconazole | decreases expression | ISO | Chst15 (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of CHST15 mRNA | CTD | PMID:35436446 | Chst15 | Rat | ethanol | multiple interactions | ISO | CHST15 (Homo sapiens) | 6480464 | [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic more ... | CTD | PMID:29432896 | Chst15 | Rat | ethanol | affects splicing | ISO | Chst15 (Mus musculus) | 6480464 | Ethanol affects the splicing of CHST15 mRNA | CTD | PMID:30319688 | Chst15 | Rat | ethanol | affects expression | ISO | Chst15 (Mus musculus) | 6480464 | Ethanol affects the expression of CHST15 mRNA | CTD | PMID:30319688 | Chst15 | Rat | folic acid | multiple interactions | ISO | Chst15 (Mus musculus) | 6480464 | [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CHST15 mRNA | CTD | PMID:22206623 | Chst15 | Rat | formaldehyde | decreases expression | ISO | CHST15 (Homo sapiens) | 6480464 | Formaldehyde results in decreased expression of CHST15 mRNA | CTD | PMID:20655997 | Chst15 | Rat | formaldehyde | increases expression | ISO | CHST15 (Homo sapiens) | 6480464 | Formaldehyde results in increased expression of CHST15 mRNA | CTD | PMID:23649840 | Chst15 | Rat | fulvestrant | multiple interactions | ISO | CHST15 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of CHST15 gene | CTD | PMID:31601247 | Chst15 | Rat | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of CHST15 mRNA | CTD | PMID:33387578 | Chst15 | Rat | hydrogen peroxide | affects expression | ISO | CHST15 (Homo sapiens) | 6480464 | Hydrogen Peroxide affects the expression of CHST15 mRNA | CTD | PMID:23410634 | Chst15 | Rat | inulin | multiple interactions | ISO | Chst15 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of CHST15 mRNA | CTD | PMID:36331819 | Chst15 | Rat | leflunomide | increases expression | ISO | CHST15 (Homo sapiens) | 6480464 | leflunomide results in increased expression of CHST15 mRNA | CTD | PMID:28988120 | Chst15 | Rat | lipopolysaccharide | multiple interactions | ISO | CHST15 (Homo sapiens) | 6480464 | [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of CHST15 mRNA | CTD | PMID:35811015 | Chst15 | Rat | manganese atom | multiple interactions | ISO | CHST15 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Chst15 | Rat | manganese(0) | multiple interactions | ISO | CHST15 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Chst15 | Rat | manganese(II) chloride | multiple interactions | ISO | CHST15 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Chst15 | Rat | menadione | affects expression | ISO | CHST15 (Homo sapiens) | 6480464 | Vitamin K 3 affects the expression of CHST15 mRNA | CTD | PMID:23410634 | Chst15 | Rat | methotrexate | decreases expression | ISO | CHST15 (Homo sapiens) | 6480464 | Methotrexate results in decreased expression of CHST15 mRNA | CTD | PMID:24449571 | Chst15 | Rat | mono(2-ethylhexyl) phthalate | multiple interactions | ISO | Chst15 (Mus musculus) | 6480464 | [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl more ... | CTD | PMID:39752319 | Chst15 | Rat | monobenzyl phthalate | multiple interactions | ISO | Chst15 (Mus musculus) | 6480464 | [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl more ... | CTD | PMID:39752319 | Chst15 | Rat | Monobutylphthalate | multiple interactions | ISO | Chst15 (Mus musculus) | 6480464 | [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl more ... | CTD | PMID:39752319 | Chst15 | Rat | monoethyl phthalate | multiple interactions | ISO | Chst15 (Mus musculus) | 6480464 | [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl more ... | CTD | PMID:39752319 | Chst15 | Rat | N-methyl-4-phenylpyridinium | increases expression | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of CHST15 mRNA | CTD | PMID:28801915 | Chst15 | Rat | nickel atom | decreases expression | ISO | CHST15 (Homo sapiens) | 6480464 | Nickel results in decreased expression of CHST15 mRNA | CTD | PMID:23195993 | Chst15 | Rat | nickel sulfate | decreases expression | ISO | CHST15 (Homo sapiens) | 6480464 | nickel sulfate results in decreased expression of CHST15 mRNA | CTD | PMID:22714537 | Chst15 | Rat | ozone | multiple interactions | ISO | CHST15 (Homo sapiens) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which results in increased expression of CHST15 more ... | CTD | PMID:26035830 | Chst15 | Rat | ozone | multiple interactions | ISO | Chst15 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased more ... | CTD | PMID:34911549 | Chst15 | Rat | panobinostat | increases expression | ISO | CHST15 (Homo sapiens) | 6480464 | panobinostat results in increased expression of CHST15 mRNA | CTD | PMID:26272509 | Chst15 | Rat | panobinostat | multiple interactions | ISO | CHST15 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... | CTD | PMID:27188386 | Chst15 | Rat | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of CHST15 mRNA | CTD | PMID:33387578 | Chst15 | Rat | PCB138 | multiple interactions | ISO | Chst15 (Mus musculus) | 6480464 | [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with more ... | CTD | PMID:25510870 | Chst15 | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Chst15 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of CHST15 mRNA | CTD | PMID:36331819 | Chst15 | Rat | phenobarbital | affects expression | ISO | Chst15 (Mus musculus) | 6480464 | Phenobarbital affects the expression of CHST15 mRNA | CTD | PMID:23091169 | Chst15 | Rat | phenylmercury acetate | increases expression | ISO | CHST15 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in increased expression of CHST15 mRNA | CTD | PMID:26272509 | Chst15 | Rat | phenylmercury acetate | multiple interactions | ISO | CHST15 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Chst15 | Rat | potassium chromate | decreases expression | ISO | CHST15 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of CHST15 mRNA | CTD | PMID:22079256 | Chst15 | Rat | potassium chromate | multiple interactions | ISO | CHST15 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CHST15 mRNA | CTD | PMID:22079256 | Chst15 | Rat | pregnenolone 16alpha-carbonitrile | increases expression | ISO | Chst15 (Mus musculus) | 6480464 | Pregnenolone Carbonitrile results in increased expression of CHST15 mRNA | CTD | PMID:28903501 | Chst15 | Rat | progesterone | multiple interactions | ISO | CHST15 (Homo sapiens) | 6480464 | [Estradiol co-treated with Progesterone] results in decreased expression of CHST15 mRNA | CTD | PMID:20660070 | Chst15 | Rat | quercetin | decreases expression | ISO | CHST15 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of CHST15 mRNA | CTD | PMID:21632981 | Chst15 | Rat | quinolin-8-ol | increases expression | ISO | CHST15 (Homo sapiens) | 6480464 | Oxyquinoline results in increased expression of CHST15 mRNA | CTD | PMID:21632981 | Chst15 | Rat | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | CHST15 (Homo sapiens) | 6480464 | [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of CHST15 mRNA | CTD | PMID:35811015 | Chst15 | Rat | SB 431542 | multiple interactions | ISO | CHST15 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... | CTD | PMID:27188386 | Chst15 | Rat | sodium arsenite | multiple interactions | ISO | CHST15 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Chst15 | Rat | Soman | decreases expression | EXP | | 6480464 | Soman results in decreased expression of CHST15 mRNA | CTD | PMID:19281266 | Chst15 | Rat | sulforaphane | increases expression | ISO | CHST15 (Homo sapiens) | 6480464 | sulforaphane results in increased expression of CHST15 mRNA | CTD | PMID:31838189 | Chst15 | Rat | tert-butyl hydroperoxide | affects expression | ISO | CHST15 (Homo sapiens) | 6480464 | tert-Butylhydroperoxide affects the expression of CHST15 mRNA | CTD | PMID:23410634 | Chst15 | Rat | thapsigargin | increases expression | ISO | CHST15 (Homo sapiens) | 6480464 | Thapsigargin results in increased expression of CHST15 mRNA | CTD | PMID:22378314 | Chst15 | Rat | titanium dioxide | decreases methylation | ISO | Chst15 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of CHST15 gene; titanium dioxide results in decreased methylation more ... | CTD | PMID:35295148 | Chst15 | Rat | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of CHST15 mRNA | CTD | PMID:33387578 | Chst15 | Rat | trichostatin A | increases expression | ISO | CHST15 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of CHST15 mRNA | CTD | PMID:24935251|PMID:26272509 | Chst15 | Rat | trichostatin A | multiple interactions | ISO | CHST15 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Chst15 | Rat | triclosan | decreases expression | ISO | CHST15 (Homo sapiens) | 6480464 | Triclosan results in decreased expression of CHST15 mRNA | CTD | PMID:30510588 | Chst15 | Rat | triphenyl phosphate | affects expression | ISO | CHST15 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of CHST15 mRNA | CTD | PMID:37042841 | Chst15 | Rat | troglitazone | increases expression | ISO | Chst15 (Mus musculus) | 6480464 | troglitazone results in increased expression of CHST15 mRNA | CTD | PMID:28973697 | Chst15 | Rat | urethane | decreases expression | ISO | CHST15 (Homo sapiens) | 6480464 | Urethane results in decreased expression of CHST15 mRNA | CTD | PMID:28818685 | Chst15 | Rat | valproic acid | affects expression | ISO | CHST15 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of CHST15 mRNA | CTD | PMID:25979313 | Chst15 | Rat | valproic acid | multiple interactions | ISO | CHST15 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Chst15 | Rat | valproic acid | increases expression | ISO | CHST15 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of CHST15 mRNA | CTD | PMID:19101580|PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:27188386|PMID:28001369 | Chst15 | Rat | vorinostat | increases expression | ISO | CHST15 (Homo sapiens) | 6480464 | vorinostat results in increased expression of CHST15 mRNA | CTD | PMID:27188386 | |






















